November 2025

Pfizer Inc. announced that it has filed a lawsuit against Metsera, Inc., its Board of Directors, and Novo Nordisk, S.A. in the Delaware Court of Chancery. The lawsuit includes claims for breach of contract, breach of fiduciary duty, and tortious interference in contract arising from Metseras alleged breach of its obligations under the merger agreement between Pfizer and Metsera.

Semaglutide significantly reduced major adverse cardiovascular events in patients with overweight or obesity with cardiovascular disease but without diabetes, as per recent research study conducted by University College London.

The U.S. Food and Drug Administration today announced actions to restrict the sale of unapproved ingestible fluoride prescription drug products for children. The FDA sent notices to four companies outlining the agencys intention to take enforcement action against those marketing unapproved fluoride-containing ingestible drugs labeled for use in children under age 3 or older children at low or moderate risk for tooth decay.

A multiple sclerosis patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a clinical trial testing whether this personalised treatment can slow or even halt the progression of the disease.

MET-I-CON 2026, the 2nd International Conference on Future Trends and Opportunities in the Pharmaceutical World, aims to provide a dynamic platform for advancing pharmaceutical knowledge and innovation.

M.Sc. in Chemistry. Candidates having research experience in the area of catalysis / electrochemistry / in organic/ inorganic synthesis.

Degree or Diploma in Pharmacy (50%) and Live Registration in Pharmacy Registration Council.

A Ph.D. in Pharmaceutical Sciences from a recognized university. First Class at Masters Degree in Pharmacy M.Pharm in relevant specialization.

M.Sc. in any branch of Life Science / Biotechnology / Chemistry / Physics / Microbiology / Agriculture / M.Tech / MPharm with experience in Teaching / Research / Industry.